OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ Boston, MA and Rolle, Switzerland, July 24, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today […]

Calgary, Canada – May 08, 2024: OncoHelix Inc. is proud to announce the official launch of OncoHelix-coLAB, a state-of-the-art laboratory within Burjeel Medical City, Abu Dhabi. This significant event was marked by an inauguration ceremony on May 6, attended by […]

News Release May 26, 2023: Introduction & Our Approach OncoHelix is a leading molecular and immune profile testing organization in Calgary, Canada, that offers specialized genomic services globally to diagnostic, research, commercial, and direct-to-consumer markets. As an internationally recognized leader, […]

Through this exclusive agreement, OncoHelix and Burjeel strive to bring personalized medicine to clinics and hospitals in the UAE. News Release April 13, 2023: Abu Dhabi, United Arab Emirates: OncoHelix with Burjeel Holdings has partnered to set up a cutting-edge […]